glp-1 for nash Resmetirom and agonists MASH: complementary rather than exclusive Glucagon-like peptide 1 and fibroblast

doi: 10.1016/j.celrep.2022.111433 45 WeberBBarrosLF

The reduction in inflammatory markers such as hs-CRP and IL-6 may contribute to improved endothelial function, reduced atherosclerotic progression, and better overall cardiometabolic health

If you have the insurance coverage and your doctor is willing to prescribe them, especially if your blood sugar is not controlled by other oral medications, then you may want to consider them

Recent studies have highlighted pancreatic involvement in children with FBS, where glycogen accumulation in pancreatic -cells contributes to dysglycemia

[Abstract]2020 Jul;104(13):5889-5898